日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/12/07 | 5,222 | 5,222 | 5,108 | 5,116 | -124 | -2.4% | 349,700 |
| 2023/12/06 | 5,241 | 5,245 | 5,164 | 5,240 | +20 | +0.4% | 345,000 |
| 2023/12/05 | 5,239 | 5,270 | 5,203 | 5,220 | -30 | -0.6% | 314,400 |
| 2023/12/04 | 5,250 | 5,268 | 5,204 | 5,250 | -58 | -1.1% | 215,300 |
| 2023/12/01 | 5,390 | 5,394 | 5,285 | 5,308 | -23 | -0.4% | 212,400 |
| 2023/11/30 | 5,250 | 5,338 | 5,238 | 5,331 | +54 | +1% | 408,200 |
| 2023/11/29 | 5,313 | 5,345 | 5,255 | 5,277 | -64 | -1.2% | 292,000 |
| 2023/11/28 | 5,325 | 5,377 | 5,277 | 5,341 | +9 | +0.2% | 424,200 |
| 2023/11/27 | 5,390 | 5,410 | 5,296 | 5,332 | -79 | -1.5% | 394,200 |
| 2023/11/24 | 5,490 | 5,490 | 5,396 | 5,411 | -45 | -0.8% | 254,500 |
| 2023/11/22 | 5,443 | 5,482 | 5,412 | 5,456 | +12 | +0.2% | 280,900 |
| 2023/11/21 | 5,398 | 5,449 | 5,278 | 5,444 | +77 | +1.4% | 378,100 |
| 2023/11/20 | 5,370 | 5,404 | 5,327 | 5,367 | -42 | -0.8% | 463,600 |
| 2023/11/17 | 5,224 | 5,409 | 5,195 | 5,409 | +198 | +3.8% | 677,700 |
| 2023/11/16 | 5,500 | 5,508 | 5,209 | 5,211 | -332 | -6% | 899,700 |
| 2023/11/15 | 5,550 | 5,567 | 5,405 | 5,543 | +63 | +1.1% | 634,000 |
| 2023/11/14 | 5,498 | 5,515 | 5,388 | 5,480 | -217 | -3.8% | 939,400 |
| 2023/11/13 | 5,700 | 5,816 | 5,677 | 5,697 | -39 | -0.7% | 260,000 |
| 2023/11/10 | 5,786 | 5,830 | 5,717 | 5,736 | -135 | -2.3% | 328,000 |
| 2023/11/09 | 5,914 | 5,954 | 5,794 | 5,871 | -12 | -0.2% | 289,000 |
| 2023/11/08 | 5,786 | 5,949 | 5,777 | 5,883 | +142 | +2.5% | 331,200 |
| 2023/11/07 | 5,839 | 5,885 | 5,741 | 5,741 | -55 | -0.9% | 206,500 |
| 2023/11/06 | 5,980 | 5,995 | 5,770 | 5,796 | -134 | -2.3% | 358,600 |
| 2023/11/02 | 6,017 | 6,023 | 5,841 | 5,930 | -55 | -0.9% | 403,500 |
| 2023/11/01 | 6,091 | 6,102 | 5,928 | 5,985 | -109 | -1.8% | 662,600 |
| 2023/10/31 | 6,222 | 6,241 | 6,004 | 6,094 | +772 | +14.5% | 1,266,900 |
| 2023/10/30 | 5,467 | 5,503 | 5,322 | 5,322 | -179 | -3.3% | 1,025,000 |
| 2023/10/27 | 5,424 | 5,507 | 5,375 | 5,501 | +77 | +1.4% | 194,600 |
| 2023/10/26 | 5,497 | 5,497 | 5,372 | 5,424 | -68 | -1.2% | 358,700 |
| 2023/10/25 | 5,576 | 5,594 | 5,473 | 5,492 | -94 | -1.7% | 257,200 |
| 2023/10/24 | 5,583 | 5,616 | 5,447 | 5,586 | +3 | +0.1% | 237,900 |
| 2023/10/23 | 5,510 | 5,600 | 5,510 | 5,583 | +73 | +1.3% | 232,800 |
| 2023/10/20 | 5,527 | 5,555 | 5,470 | 5,510 | -76 | -1.4% | 283,500 |
| 2023/10/19 | 5,650 | 5,717 | 5,586 | 5,586 | -128 | -2.2% | 206,900 |
| 2023/10/18 | 5,760 | 5,769 | 5,628 | 5,714 | -78 | -1.3% | 256,000 |
| 2023/10/17 | 5,797 | 5,813 | 5,725 | 5,792 | +49 | +0.9% | 214,800 |
| 2023/10/16 | 5,917 | 5,920 | 5,738 | 5,743 | -192 | -3.2% | 263,700 |
| 2023/10/13 | 6,060 | 6,082 | 5,901 | 5,935 | -220 | -3.6% | 362,600 |
| 2023/10/12 | 6,002 | 6,164 | 5,991 | 6,155 | +161 | +2.7% | 240,700 |
| 2023/10/11 | 6,045 | 6,055 | 5,940 | 5,994 | -45 | -0.7% | 205,000 |
| 2023/10/10 | 6,008 | 6,070 | 5,967 | 6,039 | +31 | +0.5% | 274,700 |
| 2023/10/06 | 5,993 | 6,073 | 5,974 | 6,008 | +62 | +1% | 255,600 |
| 2023/10/05 | 5,968 | 5,981 | 5,868 | 5,946 | -51 | -0.9% | 388,300 |
| 2023/10/04 | 6,051 | 6,057 | 5,976 | 5,997 | -143 | -2.3% | 286,000 |
| 2023/10/03 | 6,255 | 6,275 | 6,127 | 6,140 | -104 | -1.7% | 204,000 |
| 2023/10/02 | 6,333 | 6,406 | 6,229 | 6,244 | -85 | -1.3% | 232,500 |
| 2023/09/29 | 6,367 | 6,390 | 6,288 | 6,329 | -38 | -0.6% | 288,900 |
| 2023/09/28 | 6,422 | 6,452 | 6,311 | 6,367 | -147 | -2.3% | 331,300 |
| 2023/09/27 | 6,400 | 6,514 | 6,342 | 6,514 | +111 | +1.7% | 255,100 |
| 2023/09/26 | 6,414 | 6,468 | 6,378 | 6,403 | -15 | -0.2% | 248,000 |
101～
150
件表示中 / 3451件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 441,300円 | +2.0% | +11.5% | 2.81% | 11.43倍 | 1.41倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 参天薬 | 154,800円 | +8.2% | - | 2.13% | 19.06倍 | 1.83倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
| 久光薬 | 383,500円 | +7.3% | -3.8% | 2.35% | 18.38倍 | 1.10倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
| ツムラ | 369,200円 | +8.5% | -4.5% | 1.90% | 17.30倍 | 1.06倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| ペプチド | 196,500円 | +21.9% | +134.3% | 0.00% | 34.89倍 | 6.31倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
市場注目の銘柄
チャート関連のコラム
